These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28442935)

  • 1. New developments in the treatment of hypoactive sexual desire disorder - a focus on Flibanserin.
    Jayne CJ; Heard MJ; Zubair S; Johnson DL
    Int J Womens Health; 2017; 9():171-178. PubMed ID: 28442935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.
    Dhanuka I; Simon JA
    Expert Opin Pharmacother; 2015; 16(16):2523-9. PubMed ID: 26395164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy of Hypoactive Sexual Desire Disorder in Premenopausal Women.
    Barakeh D; Mdaihly H; Karaoui LR
    Ann Pharmacother; 2024 May; ():10600280241253273. PubMed ID: 38767282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ignorance Is Not Bliss: If We Don't Understand Hypoactive Sexual Desire Disorder, How Can Flibanserin Treat It? Commentary.
    Anderson R; Moffatt CE
    J Sex Med; 2018 Mar; 15(3):273-283. PubMed ID: 29396022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the Role of Serotonin in Female Hypoactive Sexual Desire Disorder and Treatment Options.
    Croft HA
    J Sex Med; 2017 Dec; 14(12):1575-1584. PubMed ID: 29198512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and Management of Hypoactive Sexual Desire Disorder.
    Clayton AH; Kingsberg SA; Goldstein I
    Sex Med; 2018 Jun; 6(2):59-74. PubMed ID: 29523488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Female Hypoactive Sexual Desire Disorder: A Practical Guide to Causes, Clinical Diagnosis, and Treatment.
    Kingsberg SA; Simon JA
    J Womens Health (Larchmt); 2020 Aug; 29(8):1101-1112. PubMed ID: 32460605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flibanserin: a potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women.
    Clayton AH; Dennerstein L; Pyke R; Sand M
    Womens Health (Lond); 2010 Sep; 6(5):639-53. PubMed ID: 20887163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flibanserin for female sexual dysfunction.
    Reviriego C
    Drugs Today (Barc); 2014 Aug; 50(8):549-56. PubMed ID: 25187905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoactive Sexual Desire Disorder: A Review of Epidemiology, Biopsychology, Diagnosis, and Treatment.
    Parish SJ; Hahn SR
    Sex Med Rev; 2016 Apr; 4(2):103-120. PubMed ID: 27872021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial.
    Katz M; DeRogatis LR; Ackerman R; Hedges P; Lesko L; Garcia M; Sand M;
    J Sex Med; 2013 Jul; 10(7):1807-15. PubMed ID: 23672269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study.
    Simon JA; Derogatis L; Portman D; Brown L; Yuan J; Kissling R
    J Sex Med; 2018 Mar; 15(3):387-395. PubMed ID: 29502984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study.
    Thorp J; Simon J; Dattani D; Taylor L; Kimura T; Garcia M; Lesko L; Pyke R;
    J Sex Med; 2012 Mar; 9(3):793-804. PubMed ID: 22239862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First Pharmacological Therapy for Hypoactive Sexual Desire Disorder in Premenopausal Women: Flibanserin.
    Robinson K; Cutler JB; Carris NW
    Ann Pharmacother; 2016 Feb; 50(2):125-32. PubMed ID: 26692273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.
    Derogatis LR; Komer L; Katz M; Moreau M; Kimura T; Garcia M; Wunderlich G; Pyke R;
    J Sex Med; 2012 Apr; 9(4):1074-85. PubMed ID: 22248038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.
    Portman DJ; Brown L; Yuan J; Kissling R; Kingsberg SA
    J Sex Med; 2017 Jun; 14(6):834-842. PubMed ID: 28583342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials.
    Simon JA; Thorp J; Millheiser L
    J Womens Health (Larchmt); 2019 Jun; 28(6):769-777. PubMed ID: 30707049
    [No Abstract]   [Full Text] [Related]  

  • 18. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
    Goldfischer ER; Breaux J; Katz M; Kaufman J; Smith WB; Kimura T; Sand M; Pyke R
    J Sex Med; 2011 Nov; 8(11):3160-72. PubMed ID: 21933348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder.
    Kingsberg SA; Clayton AH; Pfaus JG
    CNS Drugs; 2015 Nov; 29(11):915-33. PubMed ID: 26519340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis.
    Jaspers L; Feys F; Bramer WM; Franco OH; Leusink P; Laan ET
    JAMA Intern Med; 2016 Apr; 176(4):453-62. PubMed ID: 26927498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.